Peptide Sales Put State Pharmacy Enforcement In Focus
A move by President Donald Trump's administration to allow the compounding of six unapproved peptides won't shield pharmacies from enforcement action by state-level regulators, experts say, underscoring the uncertain legal terrain...To view the full article, register now.
Already a subscriber? Click here to view full article